Musch E - Search Results

1

Relevance of the hydrolysis and protein binding of melphalan to the treatment of multiple myeloma.

Gera S, Musch E, Osterheld HK, Loos U. Gera S, et al. Among authors: musch e. Cancer Chemother Pharmacol. 1989;23(2):76-80. doi: 10.1007/BF00273521. Cancer Chemother Pharmacol. 1989. PMID: 2910515

2

Studies on the pharmacokinetics of chlorambucil and prednimustine in patients using a new high-performance liquid chromatographic assay.

Oppitz MM, Musch E, Malek M, Rüb HP, von Unruh GE, Loos U, Mühlenbruch B. Oppitz MM, et al. Among authors: musch e. Cancer Chemother Pharmacol. 1989;23(4):208-12. doi: 10.1007/BF00451643. Cancer Chemother Pharmacol. 1989. PMID: 2924378

3

The pharmacokinetics of melphalan during intermittent therapy of multiple myeloma.

Loos U, Musch E, Engel M, Hartlapp JH, Hügl E, Dengler HJ. Loos U, et al. Among authors: musch e. Eur J Clin Pharmacol. 1988;35(2):187-93. doi: 10.1007/BF00609251. Eur J Clin Pharmacol. 1988. PMID: 3191937

4

A sensitive high-performance liquid chromatographic assay for melphalan and its hydrolysis products in blood and plasma.

Osterheld HK, Musch E, von Unruh GE, Loos U, Rauschecker H, Mühlenbruch BJ. Osterheld HK, et al. Among authors: musch e. Cancer Chemother Pharmacol. 1988;21(2):156-62. doi: 10.1007/BF00257364. Cancer Chemother Pharmacol. 1988. PMID: 3349564

5

Free plasma amino acids in patients with multiple myeloma.

Loos U, Musch E, Schulte-Vennburg M, Ferber J. Loos U, et al. Among authors: musch e. J Chemother. 1989 Jul;1(4 Suppl):1244-5. J Chemother. 1989. PMID: 16312850 No abstract available.

6

Melphalan kinetics in hyperthermic isolation perfusion of the extremities.

Loos U, Musch E, Rauschecker H, Willenbrock C. Loos U, et al. Among authors: musch e. J Chemother. 1989 Jul;1(4 Suppl):1246-7. J Chemother. 1989. PMID: 16312851 No abstract available.

7

Comparative pharmacokinetics of chlorambucil and prednimustine after oral administration.

Loos U, Musch E, Malek M, Riedel E. Loos U, et al. Among authors: musch e. Oncology. 1991;48(4):334-42. doi: 10.1159/000226953. Oncology. 1991. PMID: 1891177 Clinical Trial.

8

Pharmacokinetic and cell-biological investigation of prednimustine compared to its components chlorambucil and prednisolone.

Musch E, Loos U, Alléra A, Hügl E, Pütz I, Malek M. Musch E, et al. J Chemother. 1989 Jul;1(4 Suppl):1127-9. J Chemother. 1989. PMID: 16312803 No abstract available.

9

[Clinico-pharmacokinetic interactions of rifampicin, pyrazinamide and isoniazide].

Musch E, Loos U, Schwabe HK. Musch E, et al. Pneumologie. 1990 Feb;44 Suppl 1:486-7. Pneumologie. 1990. PMID: 2367444 German.

10

[Significance of the acetylator phenotype and initial oral/intravenous rifampicin administration in the treatment of tuberculosis].

Loos U, Musch E, Schwabe HK. Loos U, et al. Among authors: musch e. Pneumologie. 1990 Feb;44 Suppl 1:488-9. Pneumologie. 1990. PMID: 2367445 German.

Save citations to file

Email citations

Send citations to clipboard

Add to Collections

Add to My Bibliography

Create a file for external citation management software

Your saved search

Your RSS Feed

My Custom Filters

Publication date

Text availability

Article attribute

Article type

Article Language

Species

Sex

Age

Other

66 results

Search Page

Filters